The sell off is not isolated to MSB. Seems many stem cell types have been sold off in the last 2 weeks. In the below chart comparing a group of stem cell companies (XHJ in black, ATHX, CYTX, CMXI, PSTI, PRR, NBS, OSIR) you can see there has been a little sell off. Only OSIR has posted meaningful gains in the last two trading sessions.
Could Teva's formal confirmation of the PIII trial be a barometer for all stem cell companies? Are investors now waiting to see Teva throw their weight behind MSB? I dont know the answer but certainly there is (and has been in the past) some correlation here.
teva trying to hide a monster .., page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |